Daniel Wang, M.D.

Daniel Wang, M.D.

  • Internal Medicine - Hematology/Oncology
  • Melanoma
  • Skin Cancer


Daniel Wang, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He specializes in treating patients with melanoma, advanced skin cancers, and soft tissue and bone sarcomas.

Dr. Wang earned his medical degree at the Baylor College of Medicine and completed his internal medicine residency at Baylor Medicine. He gained advanced training at Vanderbilt University Medical Center, where he completed a fellowship in hematology and oncology.

Certified by the American Board of Internal Medicine in internal medicine and medical oncology, he joined the UT Southwestern faculty in 2023.

Dr. Wang is a member of the American Society of Clinical Oncology.

His research interests include exploring the effects of immunotherapy on patients with melanoma. He has authored papers in many key journals in this area and serves as a section editor for Current Oncology Reports. He also leads clinical trials in melanoma and sarcoma at UT Southwestern.

From 2021 through 2023, Dr. Wang was named a Texas Rising Star by Super Doctors in Texas Monthly.

Education & Training
  • Medical School - Baylor College of Medicine (2008-2012)
  • Residency - Baylor College of Medicine (2012-2015), Internal Medicine
  • Fellowship - Vanderbilt University Medical Center (2015-2018), Hematology Oncology
Professional Associations & Affiliations
  • American Society of Clinical Oncology
Honors & Awards
  • Texas Rising Stars 2021-2023, Super Doctors in Texas Monthly
  • Melanoma
  • Skin cancer
  • Sarcoma
  • Immunotherapy
  • Immune-related toxicities

Clinical Focus

  • Melanoma
  • Skin Cancer
  • Sarcoma

See More